Search
Descriptor in English: Axitinib
Descriptor in Spanish: Axitinib
Descriptor in Portuguese: Axitinibe
Descriptor in French: Axitinib
Entry term(s): AG 013736
AG-013736
AG013736
Inlyta
Tree number(s): D02.065.277.051
D02.241.223.100.100.115
D02.455.426.559.389.127.085.093
D03.383.129.539.487.065
D03.633.100.449.065
Scope note: A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
History Note: 2019 (2005)
DeCS UI: 57757
Descriptor UI: D000077784
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/05/21
Axitinib - Preferred
Concept UI M0489638
Scope note A benzamide and indazole derivative that acts as a TYROSINE KINASE inhibitor of the VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR. It is used in the treatment of advanced RENAL CELL CARCINOMA.
Preferred term Axitinib
AG 013736 - Narrower
Concept UI M0496201
Preferred term AG 013736
Entry term(s) AG-013736
AG013736
Inlyta - Narrower
Concept UI M0578346
Preferred term Inlyta



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey